Compare MRVI & TCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRVI | TCI |
|---|---|---|
| Founded | 2014 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 449.6M | 380.3M |
| IPO Year | 2020 | N/A |
| Metric | MRVI | TCI |
|---|---|---|
| Price | $3.61 | $53.00 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.58 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 1.8K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 75.87 |
| EPS | N/A | ★ 0.65 |
| Revenue | ★ $192,435,000.00 | $48,675,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.04 | N/A |
| P/E Ratio | ★ N/A | $76.80 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.67 | $25.50 |
| 52 Week High | $6.21 | $51.71 |
| Indicator | MRVI | TCI |
|---|---|---|
| Relative Strength Index (RSI) | 54.00 | 76.55 |
| Support Level | $3.50 | $43.01 |
| Resistance Level | $3.95 | $45.00 |
| Average True Range (ATR) | 0.18 | 1.28 |
| MACD | -0.01 | 0.76 |
| Stochastic Oscillator | 46.46 | 100.00 |
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.